These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10359816)

  • 1. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
    Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenic and atherogenic activities of lysophosphatidic acid.
    Siess W; Tigyi G
    J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
    Siess W
    Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
    Siess W
    Biochim Biophys Acta; 2002 May; 1582(1-3):204-15. PubMed ID: 12069830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
    Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
    Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells.
    Nassar T; Sachais BS; Akkawi S; Kowalska MA; Bdeir K; Leitersdorf E; Hiss E; Ziporen L; Aviram M; Cines D; Poncz M; Higazi AA
    J Biol Chem; 2003 Feb; 278(8):6187-93. PubMed ID: 12466273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.
    Kakutani M; Masaki T; Sawamura T
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):360-4. PubMed ID: 10618423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.
    Zhou Z; Subramanian P; Sevilmis G; Globke B; Soehnlein O; Karshovska E; Megens R; Heyll K; Chun J; Saulnier-Blache JS; Reinholz M; van Zandvoort M; Weber C; Schober A
    Cell Metab; 2011 May; 13(5):592-600. PubMed ID: 21531341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid-independent platelet activation by low-density lipoprotein.
    Korporaal SJ; Relou IA; van Rijn HJ; Akkerman JW
    FEBS Lett; 2001 Apr; 494(1-2):121-4. PubMed ID: 11297747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
    Zhang C; Baker DL; Yasuda S; Makarova N; Balazs L; Johnson LR; Marathe GK; McIntyre TM; Xu Y; Prestwich GD; Byun HS; Bittman R; Tigyi G
    J Exp Med; 2004 Mar; 199(6):763-74. PubMed ID: 15007093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid-induced oxidized low-density lipoprotein uptake is class A scavenger receptor-dependent in macrophages.
    Chang CL; Hsu HY; Lin HY; Chiang W; Lee H
    Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):20-5. PubMed ID: 18585471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.
    Bot M; Bot I; Lopez-Vales R; van de Lest CH; Saulnier-Blache JS; Helms JB; David S; van Berkel TJ; Biessen EA
    Am J Pathol; 2010 Jun; 176(6):3073-84. PubMed ID: 20431029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.
    Khandoga AL; Pandey D; Welsch U; Brandl R; Siess W
    Cardiovasc Res; 2011 Apr; 90(1):157-64. PubMed ID: 21106562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity.
    Smyth SS; Sciorra VA; Sigal YJ; Pamuklar Z; Wang Z; Xu Y; Prestwich GD; Morris AJ
    J Biol Chem; 2003 Oct; 278(44):43214-23. PubMed ID: 12909631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized LDL-activated platelets induce vascular inflammation.
    Daub K; Seizer P; Stellos K; Krämer BF; Bigalke B; Schaller M; Fateh-Moghadam S; Gawaz M; Lindemann S
    Semin Thromb Hemost; 2010 Mar; 36(2):146-56. PubMed ID: 20414829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.